Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Inc. Announces Closing of Non-Brokered Private Placement

Canada NewsWire February 3, 2021

Tetra Bio-Pharma Creates the ENJOUCA Business Unit

Accesswire February 3, 2021

Tetra Bio-Pharma Announces FDA Clearance on IND, allowing U.S. Reborn1(TM) Clinical Trial to Commence

Accesswire January 29, 2021

Tetra Bio-Pharma Inc. Announces a Non-Brokered Private Placement

Canada NewsWire January 27, 2021

Tetra Bio-Pharma Files New Drug Submission for REDUVO(TM) in Canada

Accesswire December 30, 2020

Tetra Bio-Pharma Confirms it is on Track to Receive Government Funding

Accesswire December 21, 2020

Tetra Bio-Pharma Hits Another Milestone Before Year End

Accesswire December 16, 2020

Tetra Bio-Pharma Provides Update on Market Potential for QIXLEEF(TM)

Accesswire December 7, 2020

Tetra Bio-Pharma Completes Major Milestone for COVID-19 Therapeutic

Accesswire December 2, 2020

Tetra Bio-Pharma Provides Update on Recent Milestones

Accesswire November 16, 2020

Tetra Bio-Pharma Provides Update on Market Potential of ARDS-003

Accesswire November 4, 2020

Tetra Bio-Pharma Inc. Acquires Common Shares of Mondias Natural Products Inc.

Canada NewsWire November 2, 2020

Tetra Bio Pharma Announces Divestiture of Lumiera Health Innovation Inc.

Accesswire October 28, 2020

Tetra Bio-Pharma, Targeted Pharmaceutical & the George Mason University Partner on ARDS-003 to Prevent & Treat COVID-19

Accesswire October 22, 2020

IntelGenx Enters Into Amended and Restated License Agreement with Tetra Bio-Pharma for Adversa® Mucoadhesive Delivery Technology for Dronabinol

GlobeNewswire October 21, 2020

Tetra Bio-Pharma Acquires Exclusive Global Technology Rights to a Mucoadhesive Delivery Technology Called Adversa(R) for its PPP-002 (dronabinol) drug candidate from IntelGenx

Accesswire October 21, 2020

Tetra Bio-Pharma Announces Positive Results in Animal Studies for Treatment of Hyperinflammatory Lung Injury

Accesswire October 20, 2020

Tetra Bio-Pharma Unveils its Commercial Vision on a Robust Chemotherapy Induced Nausea and Vomiting Portfolio

Accesswire October 7, 2020

Tetra Bio-Pharma to Present at Alpha Bronze Virtual Town Hall

Accesswire October 6, 2020

Tetra Bio-Pharma (TBP) Acquires Dronabinol Soft Gel Capsules Exclusive Canadian Distribution Rights to Establish a Strong Commercial Presence in Canada and Accelerate its Profitability

Accesswire September 30, 2020